Parrot David
Chief Financial Officer
Parrot David has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jul 28, 2026.
On the most recent filing, Parrot David is listed as Chief Financial Officer at Scribe Therapeutics, Inc. Inside the rolling window, Parrot David reported 1 open-market purchase totaling $20K in SCTX and no open-market sales.
Companies traded
Other insiders at SCTX
Insider Buying
$20K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Parrot David made?
Parrot David has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Parrot David trade?
Parrot David has filed SEC Form 4 disclosures for 1 company, including SCTX.
When was Parrot David's most recent SEC Form 4 filing?
Parrot David's most recent SEC Form 4 filing on Tracefour is dated Jul 28, 2026.
What is Parrot David's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Parrot David is listed as Chief Financial Officer.
What is Parrot David's total buy and sell value in the current window?
Inside the rolling retention window, Parrot David bought $20K and sold $0 based on SEC Form 4 filings.
What was Parrot David's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,333 SCTX shares on 2026-07-23, worth $20K, per SEC Form 4 filings.